Gap in knowledge on benefit/risk ratio of second generation antipsychotics (SGA) in the paediatric population represents a challenge for the scientific community. This study aims to analyse all suspected adverse drug reactions (ADRs) to SGA observed during the study period; compare the safety profiles of risperidone and aripiprazole; evaluate the effect of switching from risperidone to aripiprazole or to a first generation antipsychotic (FGA).

Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch / Rafaniello, Concetta; Pozzi, Marco; Pisano, Simone; Ferrajolo, Carmen; Bertella, Silvana; Sportiello, Liberata; Carnovale, Carla; Sullo, Maria Giuseppa; Cattaneo, Dario; Gentili, Marta; Rizzo, Renata; Pascotto, Antonio; Mani, Elisa; Villa, Laura; Riccio, Maria Pia; Sperandeo, Serena; Bernardini, Renato; Bravaccio, Carmela; Clementi, Emilio; Molteni, Massimo; Rossi, Francesco; Radice, Sonia; Capuano, Annalisa. - In: EXPERT OPINION ON DRUG SAFETY. - ISSN 1474-0338. - 15:sup2(2016), pp. 1-8-8. [10.1080/14740338.2016.1229301]

Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch

Pisano, Simone;SPORTIELLO, LIBERATA;PASCOTTO, ANTONIO;BRAVACCIO, CARMELA;ROSSI, FRANCESCO;CAPUANO, Annalisa
2016

Abstract

Gap in knowledge on benefit/risk ratio of second generation antipsychotics (SGA) in the paediatric population represents a challenge for the scientific community. This study aims to analyse all suspected adverse drug reactions (ADRs) to SGA observed during the study period; compare the safety profiles of risperidone and aripiprazole; evaluate the effect of switching from risperidone to aripiprazole or to a first generation antipsychotic (FGA).
2016
Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch / Rafaniello, Concetta; Pozzi, Marco; Pisano, Simone; Ferrajolo, Carmen; Bertella, Silvana; Sportiello, Liberata; Carnovale, Carla; Sullo, Maria Giuseppa; Cattaneo, Dario; Gentili, Marta; Rizzo, Renata; Pascotto, Antonio; Mani, Elisa; Villa, Laura; Riccio, Maria Pia; Sperandeo, Serena; Bernardini, Renato; Bravaccio, Carmela; Clementi, Emilio; Molteni, Massimo; Rossi, Francesco; Radice, Sonia; Capuano, Annalisa. - In: EXPERT OPINION ON DRUG SAFETY. - ISSN 1474-0338. - 15:sup2(2016), pp. 1-8-8. [10.1080/14740338.2016.1229301]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/656431
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 20
social impact